Israel Englander Medical Devices

Millennium Management LLC

$199 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
BSX Boston Scientific Corp	$129B	$952 Million 0.48% of portfolio	11,359,732	Q3 2024 Added 0.8%
MDT Medtronic PLC	$112B	$560 Million 0.28% of portfolio	6,217,469	Q3 2024 Added 212.56%
BIO Bio Rad Laboratories, Inc.	$7.97B	$195 Million 0.1% of portfolio	583,800	Q3 2024 Added 7,057.04%
ALGN Align Technology Inc	$17.5B	$191 Million 0.1% of portfolio	749,486	Q3 2024 Added 68.92%
LIVN Liva Nova PLC	$2.68B	$155 Million 0.08% of portfolio	2,958,237	Q3 2024 Added 6.57%
ABT Abbott Laboratories	$203B	$145 Million 0.07% of portfolio	1,274,334	Q3 2024 Reduced 45.27%
EW Edwards Lifesciences Corp	$43B	$75.3 Million 0.04% of portfolio	1,141,059	Q3 2024 Added 117.67%
TNDM Tandem Diabetes Care Inc	$1.94B	$60.8 Million 0.03% of portfolio	1,434,656	Q3 2024 Added 36.12%
AXNX Axonics, Inc.	$3.49B	$58.3 Million 0.03% of portfolio	836,418	Q3 2024 Added 9.95%
BRKR Bruker Corp	$7.91B	$49 Million 0.02% of portfolio	709,332	Q3 2024 Added 207.82%
GMED Globus Medical Inc	$6.44B	$46.4 Million 0.02% of portfolio	649,266	Q3 2024 Reduced 52.39%
PODD Insulet Corp	$18.5B	$40.2 Million 0.02% of portfolio	172,693	Q3 2024 Reduced 23.55%
NARI Inari Medical, Inc.	$2.62B	$39.5 Million 0.02% of portfolio	959,179	Q3 2024 Reduced 32.99%
AHCO Adapt Health Corp.	$1.31B	$36.1 Million 0.02% of portfolio	3,216,041	Q3 2024 Added 524.49%
PHG Koninklijke Philips Nv	$23.3B	$33.1 Million 0.02% of portfolio	1,012,823	Q3 2024 Reduced 9.61%
GKOS Glaukos Corp	$6.73B	$31.6 Million 0.02% of portfolio	242,226	Q3 2024 Reduced 81.05%
RXST Rx Sight, Inc.	$1.24B	$28 Million 0.01% of portfolio	567,468	Q3 2024 Added 200.91%
QTRX Quanterix Corp	$408M	$26.7 Million 0.01% of portfolio	2,062,132	Q3 2024 Added 147.01%
STE Steris PLC	$21.2B	$24.9 Million 0.01% of portfolio	102,747	Q3 2024 Added 236.74%
ATEC Alphatec Holdings, Inc.	$1.04B	$24.7 Million 0.01% of portfolio	4,432,483	Q3 2024 Added 30.43%
DXCM Dexcom Inc	$29.1B	$22.9 Million 0.01% of portfolio	341,643	Q3 2024 Added 429.75%
IRTC I Rhythm Technologies, Inc.	$2.21B	$19.6 Million 0.01% of portfolio	264,500	Q3 2024 Reduced 46.67%
ZBH Zimmer Biomet Holdings, Inc.	$22.9B	$18.9 Million 0.01% of portfolio	175,438	Q3 2024 Reduced 20.38%
PACB Pacific Biosciences Of California, Inc.	$387M	$17.7 Million 0.01% of portfolio	10,422,578	Q3 2024 Added 125.13%
TMDX Trans Medics Group, Inc.	$2.46B	$17.6 Million 0.01% of portfolio	111,837	Q3 2024 Added 49.89%
MXCT Maxcyte, Inc.	$355M	$16.3 Million 0.01% of portfolio	4,192,865	Q3 2024 Reduced 19.02%
AXGN Axogen, Inc.	$545M	$13.5 Million 0.01% of portfolio	959,592	Q3 2024 Added 40.75%
VREX Varex Imaging Corp	$615M	$12.1 Million 0.01% of portfolio	1,011,393	Q3 2024 Added 69.15%
ZIMV Zim Vie Inc.	$345M	$11.9 Million 0.01% of portfolio	749,389	Q3 2024 Reduced 45.07%
ESTA Establishment Labs Holdings Inc.	$1.01B	$11.3 Million 0.01% of portfolio	261,478	Q3 2024 Reduced 4.43%
SYK Stryker Corp	$146B	$11.3 Million 0.01% of portfolio	31,203	Q3 2024 Reduced 6.36%
CNMD Conmed Corp	$2.15B	$8.63 Million 0.0% of portfolio	119,932	Q3 2024 Reduced 78.1%
BVS Bioventus Inc.	$704M	$5.16 Million 0.0% of portfolio	431,594	Q3 2024 Reduced 21.53%
NPCE Neuro Pace Inc	$230M	$5.16 Million 0.0% of portfolio	739,993	Q3 2024 Added 7.86%
SRDX Surmodics Inc	$549M	$4.65 Million 0.0% of portfolio	119,835	Q3 2024 Added 55.64%
PRCT Procept Bio Robotics Corp	$4.13B	$4.37 Million 0.0% of portfolio	54,606	Q3 2024 Reduced 41.09%
IRMD Iradimed Corp	$654M	$4.03 Million 0.0% of portfolio	80,227	Q3 2024 Reduced 3.4%
CVRX Cv Rx, Inc.	$277M	$3.83 Million 0.0% of portfolio	435,170	Q3 2024 Added 634.99%
AORT Artivion, Inc.	$1.08B	$3.52 Million 0.0% of portfolio	132,262	Q3 2024 Reduced 72.79%
IART Integra Lifesciences Holdings Corp	$1.92B	$3.49 Million 0.0% of portfolio	191,803	Q3 2024 Added 994.95%
CERS Cerus Corp	$294M	$3.29 Million 0.0% of portfolio	1,891,646	Q3 2024 Added 29.96%
TMCI Treace Medical Concepts, Inc.	$442M	$3.22 Million 0.0% of portfolio	554,492	Q3 2024 Reduced 19.17%
UFPT Ufp Technologies Inc	$2.26B	$3.14 Million 0.0% of portfolio	9,929	Q3 2024 Reduced 62.82%
CLPT Clear Point Neuro, Inc.	$268M	$3.09 Million 0.0% of portfolio	275,284	Q3 2024 Reduced 40.86%
OFIX Orthofix Medical Inc.	$378M	$3.04 Million 0.0% of portfolio	194,360	Q3 2024 Reduced 50.52%
AVNS Avanos Medical, Inc.	$831M	$2.76 Million 0.0% of portfolio	114,983	Q3 2024 Reduced 6.35%
NVRO Nevro Corp	$150M	$2.63 Million 0.0% of portfolio	471,704	Q3 2024 Reduced 50.69%
ITGR Integer Holdings Corp	$4.42B	$2.45 Million 0.0% of portfolio	18,855	Q3 2024 Added 155.45%
DCTH Delcath Systems, Inc.	$86M	$1.85 Million 0.0% of portfolio	205,107	Q3 2024 Added 610.3%
INMD In Mode Ltd.	$1.52B	$1.71 Million 0.0% of portfolio	100,780	Q3 2024 New

Shares Options

Israel Englander

Israel Englander is the founder and CEO of Millennium Management, a successful investment firm that uses technology and data-driven approaches to investing. Englander is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Israel Englander's portfolio

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account